Skip to main content
OpenTrials
Completed

NCT Number: NCT05986058

Preliminary Efficacy of a Technology-based Physical Activity Intervention for Older Korean Adults During the COVID-19 Pandemic

This study tested preliminary efficacy of a hybrid (web-based and center-based) PA intervention combining use of a smartwatch and mobile application. The 12-week hybrid PA intervention included 120 older Korean adults and was concurrently implemented in-person at the local senior center and at-home through a web-based modality. Overall, increases were evident in systolic/diastolic blood pressure, total cholesterol, and high-density-lipoprotein at posttest, with decreases seen for triglyceride levels. Participants showed improvements in muscular function and cardiopulmonary endurance.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Health Physical Function

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mokdong Senior Welfare Center

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 60 and over
  • enrolled member at the participating senior center for at least three years
  • fluent in Korean

Exclusion criteria

  • younger than 60 years old
  • less than three years enrollment at the senior center
  • cannot read and speak Korean

Treatment and study plan

Golden Circle

Behavioral

The original Golden Circle project was deployed in response to the COVID-19 pandemic and the need to implement remote social services in South Korea. Golden Circle had the aim of building a case management model using a healthcare-oriented automation system based on wearable devices (smartwatches and mobile applications). Through innovative system expansions, the goals were to promote healthful CVH and physical function and cultivate self-care management skills in older Korean adults.

Primary outcomes

  1. Cardiovascular health

    Time frame: Pre (baseline) and posttest (through study completion, 12 weeks later from the baseline)

    systolic and diastolic blood pressure, total cholesterol, high-density lipoprotein, and triglycerides

Secondary outcomes

  1. Physical function

    Time frame: Pre (baseline) and posttest (through study completion, 12 weeks later from the baseline)

    muscular function and cardiopulmonary endurance

Sponsors and collaborators

Lead sponsor

University of Illinois at Urbana-Champaign

Other

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 14, 2023
Registry last updated
Aug 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.